References
- American Academy of Sleep MedicineInternational Classification of Sleep Disorders2nd EditionDiagnostic and Coding ManualWestchester, ILAmerican Academy of Sleep Medicine2005
- DrakeCLRoehrsTRichardsonGWalshJKRothTShift work sleep disorder: prevalence and consequences beyond that of symptomatic day workersSleep20042781453146215683134
- HorstmannSHessCWBassettiCGuggerMMathisJSleepiness-related accidents in sleep apnea patientsSleep200023338338910811382
- KingshottRNCowanJOJonesDRThe role of sleep-disordered breathing, daytime sleepiness, and impaired performance in motor vehicle crashes – a case control studySleep Breath200482617215211390
- LindbergECarterNGislasonTJansonCRole of snoring and daytime sleepiness in occupational accidentsAm J Respir Crit Care Med2001164112031203511739131
- DauvilliersYAPaquereauJBastujiHDronotXWeilJJViot-BlancVPsychological health in central hypersomnia: The French Harmony StudyJ Neurol Neurosurg Psychiatry200980663664119211597
- MulgrewATRyanCFFleethamJAThe impact of obstructive sleep apnea and daytime sleepiness on work limitationSleep Med200791425317825611
- PucaFMPerrucciSPrudenzanoMPQuality of life in shift work syndromeFunct Neurol19961152612689119269
- SforzaEJanssensJPRochatTIbanezVDeterminants of altered quality of life in patients with sleep-related breathing disordersEur Respir J200321468268712762357
- KeamSWalkerMCTherapies for narcolepsy with or without cataplexy: evidence-based reviewCurr Opin Neurol200720669970317992092
- SchwartzJRLRothTShift work sleep disorder. Burden of illness and approaches to managementDrugs200666182357237017181377
- SmithIEQuinnellTGPharmacotherapies for obstructive sleep apnoea. Where are we now?Drugs200464131385139915212557
- HauckWAdamPBobierCLandmesserNUse of large-scale chromatography in the preparation of armodafinilChirality200820889689918506833
- KrakowBMelendrezDFerreiraEPrevalence of insomnia symptoms in patients with sleep-disordered breathingChest200112061923192911742923
- HirshkowitzMThe clinical consequences of obstructive sleep apnea and associated excessive sleepinessJ Fam Pract200857SupplS9S1618687238
- JohnsMWA new method for measuring daytime sleepiness: the Epworth sleepiness scaleSleep19911465405451798888
- HardingeFMPitsonDJStradlingJRUse of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoeaRespir Med19958996176207494915
- JohnsMWSensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standardJ Sleep Res20009151110733683
- HeatonKAndersonDA psychometric analysis of the Epworth Sleepiness ScaleJ Nurs Meas200715317718818232617
- WeaverTEMaislinGDingesDFRelationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioningSleep200730671171917580592
- DarkeSKayeSMcKetinRDuflouJMajor physical and psychological harms of methamphetamine useDrug Alcohol Rev200827325326218368606
- RobertsonPJrHellriegelETClinical pharmacokinetic profile of modafinilClin Pharmacokinet200342212313712537513
- WongYNKingSPSimcoeDOpen-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjectsJ Clin Pharmacol199939328128810073328
- WongYNSimcoeDHartmanLNA double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteersJ Clin Pharmacol199939130409987698
- Food and Drug AdministrationFDA-approved Labeling Text for NDA 21-875/NUVIGIL™ (armodafinil) Tablets2007 URL: http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021875lbl.pdfAccessed June 30, 2009
- WisorJPDementWCAimoneLWilliamsMBozyczko-CoyneDArmodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the ratPharmacol Biochem Behav200685349249917134745
- BeckPOdleAWallace-HuittTSkinnerRDGarcia-RillEModafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonistsSleep200831121647165419090320
- RaoYLiuZWBorokEProlonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neuronsJ Clin Invest2007117124022403318060037
- MitchellHABogenpohlJWLilesLCBehavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic–dopaminergic mechanism of actionPharmacol Biochem Behav200891221722218703079
- QuWMHuangZLXuXHMatsumotoNUradeYDopaminergic D1 and D2 receptors are essential for the arousal effect of modafinilJ Neurosci200828348462846918716204
- MignotENishinoSGuilleminaultCDementWCModafinil binds to the dopamine uptake carrier site with low affinitySleep19941754364377991954
- VolkowNDFowlerJSLoganJEffects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implicationsJAMA2009301111148115419293415
- DarwishMKirbyMHellriegelETYangRRobertsonPJrPharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studiesClin Drug Investig200929287100
- DarwishMKirbyMRobertsonPJrHellriegelETInteraction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjectsClin Pharmacokinet2008471617418076219
- YoungTPaltaMDempseyJSkatrudJWeberSBadrSThe occurrence of sleep-disordered breathing among middle-aged adultsN Engl J Med199332817123012358464434
- RothTWhiteDSchmidt-NowaraWEffects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adultsClin Ther200628568970616861091
- HirshkowitzMBlackJEWesnesKNieblerGAroraSRothTAdjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndromeRespir Med2007101361662716908126
- HullSLankfordAVinceBNieblerGEAroraSArmodafinil improves fatigue in patients with excessive sleepiness due to obstructive sleep apnea/hypopnea syndromeAmerican Psychiatric Association Annual MeetingToronto, CanadaMay 25, 2006 [Abstract No. 127]
- RothTRipponGAAroraSArmodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apneaSleep Breath2008121536217874255
- RothTCzeislerCAWalshJKRandomized, double-blind, placebo-controlled study of armodafinil for the treatment of excessive sleepiness associated with chronic shift work sleep disorderNeuropsychopharmacology200530SupplS140 [Abstract No. 161]
- CzeislerCAWalshJKWesnesKAAroraSARothTArmodafinil for the treatment of excessive sleepiness associated with shiftwork disorder: A randomized controlled studyMayo Clinic Proceedings2009841195897219880686
- HarshJRHaydakRRosenbergRThe efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsyCurr Med Res Opin200622476177416684437
- McMenaminTMA time to work: recent trends in shift work and flexible schedulesMonthly Labor Review122007315 URL: http://www.bls.gov/opub/mlr/2007/12/art1full.pdfAccessed April 2, 2009
- AkerstedtTShift work and disturbed sleep/wakefulnessOccup Med (Lond)2003532899412637592
- BoggildHKnutssonAShift work, risk factors and cardiovascular diseaseScand J Work Environ Health1999252859910360463
- KnutssonAHealth disorders of shift workersOccup Med (Lond)200353210310812637594
- CzeislerCAWalshJKWesnesKAAroraSARothTArmodafinil for the treatment of excessive sleepiness associated with shiftwork disorder: A randomized controlled studyMayo Clinic Proceedings2009841195897219880686
- LongstrethWTJrTonTGKoepsellTGersukVHHendricksonAVeldeSPrevalence of narcolepsy in King County, Washington, USASleep Med200910442242619013100
- MignotESleep, sleep disorders and hypocretin (orexin)Sleep Med20045Suppl 1S2S815301991
- BlackJHullSGTillerJYangRHarshJRMaintenance of efficacy, safety and tolerability of armodafinil: An open-label extension study [Abstract 0419]Sleep200932SupplA139
- SchwartzJRKhanAMcCallVWeintraubJTillerJA 12 month or more open-label study of the efficacy and tolerability of armodafinil [Abstract 0148]Sleep200932SupplA50A51
- BoganRTillerJYangRYouakimJRothTArmodafinil for excessive sleepiness associated with jet lag disorder [Abstract 0153]Sleep200932SupplA52